PFE Financial Facts

Research and development expenses: 1.75B
Net income attributable to Pfizer Inc.: 2.02B
See Full Income Statement

Long-term debt: 30.46B
Accounts payable: 3.26B
See Full Balance Sheet

Pfizer Inc. (PFE) Earnings

  |   Expand Research on PFE
Next EPS Date 10/27/16 *Est. EPS Growth Rate +14.3% *Last Qtr.
Average EPS % Beat Rate +11.2% Revenue Growth Rate +19.1% *Last Qtr.
Average % Move 1-Wk after EPS -1.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
1/29/13 Q412 $0.47$0.44 +$0.03$15.1B$14.4B = Details
2/1/11 Q410 $0.47$0.46 +$0.01$17.56B$16.97B = Details
1/31/12 Q411 $0.50$0.47 +$0.03$16.7B$16.61B = Details
4/28/15 Q115 $0.51$0.49 +$0.02$10.86B$10.79B Details
10/27/15 Q315 $0.60$0.51 +$0.09$12.1B$11.56B Details
11/2/10 Q310 $0.54$0.51 +$0.03N/AN/A N/A Details
2/2/16 Q415 $0.53$0.52 +$0.01$14.05B$13.57B Details
1/28/14 Q413 $0.56$0.52 +$0.04$13.56B$13.35B = Details